• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    MESA LABS DECLARES QUARTERLY DIVIDEND

    1/6/25 3:00:00 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials
    Get the next $MLAB alert in real time by email

    LAKEWOOD, Colo., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 17, 2025, to shareholders of record at the close of business on February 28, 2025.

    About Mesa Laboratories, Inc.

    Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.

    Forward Looking Statements

    This press release may contain information that constitutes forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from our historical experience and present expectations or projections.  Forward-looking statements include statements relating to revenues and growth, operating results, profit margin pressure, industry conditions, economic conditions, demand, competition, the effects of additional actions taken to become more efficient or lower costs, risks related to the integration of acquired businesses, changes in legal and regulatory matters, the ability to generate additional cash flow, and any events or developments that we expect or anticipate will occur in the future. Generally, the words "expect," "anticipate," "seek," "intend," "plan," "believe," "could," "estimate," "may," "target," "project," and similar expressions identify forward-looking statements. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. These statements are based upon current information and expectations. Actual results may differ materially from those estimated or anticipated as a result of these risks and unknowns or other risks and uncertainties. For additional information concerning these and other risks and uncertainties that could affect these statements, and our business, see our Annual Report on Form 10-K for the year ended March 31, 2024, as well as other risks and uncertainties detailed from time to time in our reports on Forms 10-Q and 8-K subsequently filed with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. We undertake no obligation to republish revised forward-looking statements to reflect events or circumstances after the date hereof, to provide any updates, or to reflect the occurrence of future events.

    For more information about the Company, please visit its website at www.mesalabs.com



    CONTACT: Gary Owens; President and CEO, or John Sakys; CFO, both of Mesa Laboratories, Inc., +1-303-987-8000

    Primary Logo

    Get the next $MLAB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MLAB

    DatePrice TargetRatingAnalyst
    8/28/2024$120.00Underweight
    Wells Fargo
    1/4/2024$100.00 → $125.00In-line → Outperform
    Evercore ISI
    More analyst ratings

    $MLAB
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 Results

      LAKEWOOD, Colo., May 28, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter ("4Q25") and full fiscal year ("FY25") ended March 31, 2025 (amounts in thousands). Fourth quarter FY25 compared to fourth quarter FY24: Revenues increased 5.5%Non-GAAP core organic revenues growth1 was 6.3%Operating income increased 100.5% to $1,469Non-GAAP adjusted operating income ("AOI") excluding unusual items2 decreased 18.0% and was 19.7% as a percentage of revenues   Full FY25 compared to full FY24:

      5/28/25 8:00:16 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • MESA LABS DECLARES QUARTERLY DIVIDEND

      LAKEWOOD, Colo., April 07, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 16, 2025, to shareholders of record at the close of business on May 30, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase p

      4/7/25 3:00:00 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Mesa Labs Announces Third Quarter Results

      LAKEWOOD, Colo., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its third fiscal quarter ("3Q25") ended December 31, 2024 (amounts in thousands). Third quarter FY 2025 compared to third quarter FY 2024: Revenues increased 17.5%Non-GAAP core organic revenues1 increase was 13.2%Operating income increased 8,725% to $5,779Non-GAAP adjusted operating income excluding unusual items2 increased 13.3% and was 23.5% as a percentage of revenues We operate our business in four divisions: Sterilization and Disinfection Control ("SDC"

      2/4/25 8:00:38 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials

    $MLAB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Mesa Laboratories Inc.

      SC 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

      10/15/24 1:29:56 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G/A filed by Mesa Laboratories Inc. (Amendment)

      SC 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

      2/13/24 5:09:39 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G/A filed by Mesa Laboratories Inc. (Amendment)

      SC 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

      1/23/24 2:18:26 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials

    $MLAB
    Financials

    Live finance-specific insights

    See more
    • MESA LABS DECLARES QUARTERLY DIVIDEND

      LAKEWOOD, Colo., April 07, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 16, 2025, to shareholders of record at the close of business on May 30, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase p

      4/7/25 3:00:00 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • MESA LABS DECLARES QUARTERLY DIVIDEND

      LAKEWOOD, Colo., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 17, 2025, to shareholders of record at the close of business on February 28, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increa

      1/6/25 3:00:00 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • MESA LABS DECLARES QUARTERLY DIVIDEND

      LAKEWOOD, Colo., Oct. 02, 2024 (GLOBE NEWSWIRE) --  Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 16, 2024, to shareholders of record at the close of business on November 29, 2024. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, in

      10/2/24 2:00:00 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials

    $MLAB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President and CEO Owens Gary M exercised 21,000 shares at a strike of $122.98 and sold $2,602,110 worth of shares (21,000 units at $123.91) (SEC Form 4)

      4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

      3/24/25 1:38:04 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Director Sullivan John James gifted 2,000 shares, decreasing direct ownership by 7% to 25,878 units (SEC Form 4)

      4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

      11/25/24 11:40:41 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • President and CEO Owens Gary M was granted 11,559 shares and sold $571,736 worth of shares (5,069 units at $112.79), increasing direct ownership by 18% to 43,337 units (SEC Form 4)

      4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

      10/29/24 8:18:57 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials

    $MLAB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Wells Fargo initiated coverage on Mesa Laboratories with a new price target

      Wells Fargo initiated coverage of Mesa Laboratories with a rating of Underweight and set a new price target of $120.00

      8/28/24 7:48:06 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Mesa Laboratories upgraded by Evercore ISI with a new price target

      Evercore ISI upgraded Mesa Laboratories from In-line to Outperform and set a new price target of $125.00 from $100.00 previously

      1/4/24 8:29:10 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials

    $MLAB
    Leadership Updates

    Live Leadership Updates

    See more
    • Mesa Laboratories Appoints Mark Capone to its Board of Directors

      LAKEWOOD, Colo., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa", "we", "us", or "our"), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced the appointment of Mark Capone to its Board of Directors (the "Board"), effective January 5, 2024. Dr. John Sullivan, Ph.D., Chairman of the Board of Directors, stated: "We are pleased to welcome Mark to Mesa's Board. Mark is an accomplished life sciences executive with significant leadership and acquisitions experience spanning biopharmaceuticals, life science tools, and clinical genomics. We believe Mark's insights will be pivotal to Mesa

      1/8/24 8:00:00 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Mesa Laboratories, Inc. Appoints Shiraz Ladiwala as Lead Independent Director

      LAKEWOOD, Colo., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa" or the "Company") today announced that Shiraz Ladiwala has been appointed to serve as the Lead Independent Director of its Board of Directors ("Board"), effective November 3, 2022. Mr. Ladiwala assumes this newly re-created role as an expansion of his current responsibilities on the Board, on which he has served since October 2021. Mr. Ladiwala was selected for this important role due to the thoughtful leadership and contributions he has made to the Board as well as the exceptional breadth of his professional experience. Mr. Ladiwala said, "I am delighted to accept this leadership role on Mes

      11/4/22 3:49:04 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Mesa Laboratories Appoints Tony Tripeny to its Board of Directors

      LAKEWOOD, Colo., June 27, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) announced the appointment of Tony Tripeny to its Board of Directors (the "Board"), effective June 23, 2022. Tony was previously the Executive Vice President and Chief Financial Officer of Corning, Incorporated and retired on May 2, 2022. With Mr. Tripeny's appointment, the Mesa Laboratories, Inc. Board of Directors will be comprised of eight directors, six of whom are independent. Mr. Tripeny is likely to be appointed to the Audit Committee and brings extensive financial experience to the Board. The Board is committed to ongoing director refreshment and continues to consider new, qualified independent

      6/27/22 8:01:00 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials

    $MLAB
    SEC Filings

    See more
    • Mesa Laboratories Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

      8-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

      6/6/25 3:00:33 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • SEC Form 10-K filed by Mesa Laboratories Inc.

      10-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

      5/28/25 8:01:28 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Mesa Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

      5/28/25 8:00:10 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials